Blue Earth Therapeutics Overview
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$76.5M
- Investors
-
5
Blue Earth Therapeutics General Information
Description
Operator of a radiopharmaceutical company intended to offer targeted radiotherapeutics to treat patients with cancer. The company is developing and designing radioligand therapies that deliver greater doses to tumors while sparing healthy tissue, enabling healthcare professionals to treat prostate and other forms of cancer.
Contact Information
Website
www.blueearththerapeutics.comCorporate Office
- The Oxford Science Park Magdalen Centre
- Robert Robinson Avenue
- Oxford OX4 4GA
- England, United Kingdom
Corporate Office
- The Oxford Science Park Magdalen Centre
- Robert Robinson Avenue
- Oxford OX4 4GA
- England, United Kingdom
Blue Earth Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 30-Oct-2024 | $76.5M | Completed | Clinical Trials - Phase 2 |
Blue Earth Therapeutics Patents
Blue Earth Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026185117-A1 | Registrations of images in medical applications in groups | Pending | 03-Mar-2025 | ||
| WO-2026178064-A1 | Deep learning based vessel suppression on contrast enhanced mri images | Pending | 18-Feb-2025 | ||
| WO-2026171959-A1 | Fap-targeting fluorescent probes | Pending | 17-Feb-2025 | ||
| WO-2026171961-A1 | Fap-targeting fluorescent probes | Pending | 17-Feb-2025 | ||
| EP-4764013-A1 | Recovery of gadolinium from solutions comprising gadolinium-based contrast agents | Inactive | 19-Dec-2024 | C22B59/00 |
Blue Earth Therapeutics Signals
Blue Earth Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bracco Group | Holding Company | Minority | ||
| PBM Capital | PE/Buyout | Minority | ||
| Sands Capital | Growth/Expansion | Minority | ||
| Soleus Capital | Asset Manager | Minority | ||
| Woodline Partners | Hedge Fund | Minority |
Blue Earth Therapeutics Investments & Acquisitions (11)
Blue Earth Therapeutics’s most recent deal was a PIPE with Polarean Imaging for . The deal was made on 22-May-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Polarean Imaging | 22-May-2024 | PIPE | Diagnostic Equipment | ||
| Bracco-Eisai | 31-Mar-2023 | Merger/Acquisition | Diagnostic Equipment | ||
| Polarean Imaging | 06-Apr-2021 | PIPE | Diagnostic Equipment | ||
| Polarean Imaging | 13-Mar-2020 | PIPE | Diagnostic Equipment | ||
| Blue Earth Diagnostics | 01-Aug-2019 | Merger/Acquisition | Drug Discovery |
Blue Earth Therapeutics Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SurgVision | Munich, Germany | 2013 | |
| Blue Earth Diagnostics | Oxford, United Kingdom | 2013 |
Blue Earth Therapeutics FAQs
-
Where is Blue Earth Therapeutics headquartered?
Blue Earth Therapeutics is headquartered in Oxford, United Kingdom.
-
What is the size of Blue Earth Therapeutics?
Blue Earth Therapeutics has 26 total employees.
-
What industry is Blue Earth Therapeutics in?
Blue Earth Therapeutics’s primary industry is Biotechnology.
-
Is Blue Earth Therapeutics a private or public company?
Blue Earth Therapeutics is a Private company.
-
What is Blue Earth Therapeutics’s current revenue?
The current revenue for Blue Earth Therapeutics is .
-
How much funding has Blue Earth Therapeutics raised over time?
Blue Earth Therapeutics has raised $76.5M.
-
Who are Blue Earth Therapeutics’s investors?
Bracco Group, PBM Capital, Sands Capital, Soleus Capital, and Woodline Partners have invested in Blue Earth Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process